-
Verastem Oncology Announces Strategic Transition Plan to Accelerate Next Phase of Growth
15 Dec 2025 21:44 GMT
… the Velcade® development program at Millennium Pharmaceuticals. He also held a number …
-
Pevonedistat hydrochloride by Millennium Pharmaceuticals for Essential Thrombocythemia: Likelihood of Approval
27 Oct 2023 16:35 GMT
… the below form
By GlobalData
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals (Takeda Oncology), a subsidiary …
-
Pevonedistat hydrochloride by Millennium Pharmaceuticals for Solid Tumor: Likelihood of Approval
10 Feb 2023 09:11 GMT
… is under clinical development by Millennium Pharmaceuticals and currently in Phase I … refractory acute lymphocytic leukemia.
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals is a biopharmaceutical company that …
-
Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight
06 Nov 2025 23:45 GMT
… Pharma, Five Prime Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Novartis Oncology, Takeda, Mundipharma …
-
AKTIS ONCOLOGY APPOINTS KYLE KUVALANKA CHIEF FINANCIAL OFFICER
05 Nov 2025 12:36 GMT
… Strategy and Alliance Management at Millennium Pharmaceuticals, the Takeda Oncology Company, and … Vice President, Investor Relations at Millennium Pharmaceuticals. Mr. Kuvalanka holds an MBA …
-
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
28 Oct 2025 12:51 GMT
… in the U.S. by Millennium Pharmaceuticals, Inc., a wholly owned subsidiary …
-
Lupus Nephritis Market to Advance at a CAGR of 8.5% During the Forecast Period (2025-2034) | DelveInsight
07 Oct 2025 00:54 GMT
… Tianqing Pharmaceutical Group Co., Ltd., Millennium Pharmaceuticals, Inc., Takeda, Synthekine, Hangzhou Sumgen …
-
In ‘biotech winter,’ Boston startups, jobs, and science are being swept away
15 Sep 2025 10:15 GMT
… Dunsire, the former CEO of Millennium Pharmaceuticals who has spent more than …
-
Merkel Cell Carcinoma Market Set for Rapid Growth in the Coming 10 Years Across the 7MM | DelveInsight
20 Aug 2025 17:00 GMT
… , including Incyte Corporation, Merck, Pfizer, Millennium Pharmaceuticals Inc., Novartis, Exelixis, Bristol-Myers …
-
Merkel Cell Carcinoma Market Set For Rapid Growth In The Coming 10 Years Across The 7MM Delveinsight
20 Aug 2025 17:29 GMT
… , including Incyte Corporation, Merck, Pfizer, Millennium Pharmaceuticals Inc., Novartis, Exelixis, Bristol-Myers …